Currently predicting for Wed, 3 Jul 2024

Trading levels for ARDX

Fibonacci Support & Resistance Levels

Level Price
R3 7.01 32.70%
R2 6.47 22.57%
R1 6.14 16.31%
Price 5.28
S1 5.07 -3.94%
S2 4.74 -10.20%
S3 4.21 -20.33%

Accumulated Volume Support & Resistance Levels

Level Price
R3 6.46 22.35%
R2 6.40 21.21%
R1 6.16 16.67%
Price 5.28
S1 0 -
S2 0 -
S3 0 -

ARDX Predictions History

2 weeks ago
PredictionBot.Warren predicted that ARDX for Jun. 18th is going $6.38 (7.15%)

2 weeks ago
PredictionBot.Kathy predicted that ARDX for Jun. 18th is going $6.43 (8.00%)

2 weeks ago
jwyckoff1 predicted that ARDX for Jun. 18th is going

Rank:

1 month ago
PredictionBot.Kathy predicted that ARDX for May. 28th is going $6.93 (2.64%)

1 month ago
PredictionBot.Warren predicted that ARDX for May. 28th is going $6.86 (1.65%)

1 month ago
thedean2010 predicted that ARDX for May. 28th is going

3 months ago
PredictionBot.Kathy predicted that ARDX for Mar. 27th is going $7.60 (2.61%)

3 months ago
PredictionBot.Warren predicted that ARDX for Mar. 27th is going $7.53 (1.68%)

3 months ago
dycg9wtcqf.411978 predicted that ARDX for Mar. 27th is going

Rank:

4 months ago
PredictionBot.Kathy predicted that ARDX for Feb. 21st is going $8.76 (3.05%)

Click to get the best stock tips daily for free!

About Ardelyx

Ardelyx Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel syndrome with constipation, as well as in Phase III clinical trial to control serum phosphorus in adult pat... ARDX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT